Trapidil, a platelet-derived growth factor antagonist, was first developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease. It is grouped under the following drug class(es): Antianginals and Vasodilating agents. Its therapeutic use is listed as angina. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rocornal and Trapymin. Its PubChem CID is 5531.
Trapidil
| CAS No | 15421-84-8 |
|---|---|
| Molecular Formula | C10H15N5 |
| Molecular Weight | 205.26 g/mol |
| Synonyms | N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Trapidil, a platelet-derived growth factor antagonist, was first developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.
The listed CAS number is 15421-84-8.
The listed molecular formula is C10H15N5.
The listed molecular weight is 205.26 g/mol.
N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine.
The source lists Rocornal and Trapymin.